Alessandra Bandera Selected Research

tucaresol

9/2005	Analysis of the env V3 sequences obtained from patients with HIV type 1 infection treated with the immune modulant agent tucaresol.
8/2004	Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandra Bandera Research Topics

Disease

26	Infections 07/2022 - 09/2005
26	COVID-19 05/2022 - 01/2020
15	HIV Infections (HIV Infection) 03/2022 - 08/2004
6	Neoplasms (Cancer) 07/2022 - 03/2013
6	Inflammation (Inflammations) 01/2021 - 08/2015
4	Pneumonia (Pneumonitis) 05/2022 - 08/2019
4	Sepsis (Septicemia) 05/2022 - 10/2018
4	Viremia 02/2021 - 08/2010
3	Septic Shock (Toxic Shock Syndrome) 05/2022 - 01/2021
3	Acute Kidney Injury (Acute Renal Failure) 05/2022 - 10/2018
3	Coinfection 11/2021 - 01/2020
2	Critical Illness (Critically Ill) 01/2022 - 12/2021
2	Reinfection 01/2022 - 01/2021
2	Ventilator-Associated Pneumonia 01/2022 - 01/2021
2	Arthritis (Polyarthritis) 01/2022 - 01/2022
2	Disease Progression 01/2022 - 01/2019
2	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2022 - 01/2022
2	Hypersensitivity (Allergy) 12/2021 - 09/2021
2	Respiratory Insufficiency (Respiratory Failure) 02/2021 - 10/2020
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 08/2015
2	Dysbiosis 08/2020 - 01/2018
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 01/2019
1	Bites and Stings (Sting) 07/2022
1	Nocardia Infections 05/2022
1	Melanoma (Melanoma, Malignant) 03/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Rheumatic Diseases (Rheumatism) 01/2022
1	Fatigue 01/2022
1	Somatoform Disorders (Somatoform Disorder) 01/2022
1	Rheumatoid Arthritis 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Human Influenza (Influenza) 12/2021

Drug/Important Bio-Agent (IBA)

9	AntibodiesIBA 02/2022 - 01/2020
8	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2012
7	VaccinesIBA 03/2022 - 01/2021
6	Biomarkers (Surrogate Marker)IBA 10/2021 - 03/2015
5	BNT162 VaccineIBA 01/2022 - 01/2021
4	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
3	Immune Checkpoint InhibitorsIBA 07/2022 - 01/2021
3	COVID-19 VaccinesIBA 01/2022 - 09/2021
3	Antirheumatic Agents (DMARD)IBA 01/2022 - 01/2022
3	Biological ProductsIBA 01/2022 - 01/2022
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2021
3	Antiviral Agents (Antivirals)IBA 12/2021 - 03/2014
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2021 - 07/2020
3	Oxygen (Dioxygen)IBA 10/2021 - 01/2021
3	C-Reactive ProteinIBA 10/2021 - 01/2021
3	ABO Blood-Group SystemIBA 01/2021 - 10/2020
2	Pharmaceutical PreparationsIBA 07/2022 - 08/2015
2	MicroRNAs (MicroRNA)IBA 03/2022 - 11/2014
2	2019-nCoV Vaccine mRNA-1273IBA 02/2022 - 01/2021
2	CytokinesIBA 01/2022 - 09/2005
2	Immunoglobulin M (IgM)IBA 01/2022 - 11/2021
2	Immunoglobulin A (IgA)IBA 01/2022 - 11/2021
2	Immunomodulating AgentsIBA 01/2022 - 01/2017
2	Neutralizing AntibodiesIBA 10/2021 - 01/2021
2	Ferritins (Ferritin)IBA 02/2021 - 01/2021
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 02/2021 - 07/2020
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2021
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2018 - 12/2010
2	HDL CholesterolIBA 09/2016 - 01/2016
2	tucaresolIBA 09/2005 - 08/2004
1	Chimeric Antigen ReceptorsIBA 07/2022
1	proadrenomedullinIBA 05/2022
1	Insulin (Novolin)FDA Link 03/2022
1	Nerve Growth Factors (Neurotrophins)IBA 03/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 03/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 03/2022
1	Fosfomycin FDA Link 02/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Interleukin-15 (Interleukin 15)IBA 01/2022
1	ChemokinesIBA 01/2022
1	GlucocorticoidsIBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	Platelet Factor 4IBA 01/2022
1	Antiphospholipid AntibodiesIBA 01/2022
1	SteroidsIBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 12/2021
1	Glycoproteins (Glycoprotein)IBA 12/2021
1	Oseltamivir (Tamiflu)FDA Link 12/2021
1	Zanamivir (Relenza)FDA Link 12/2021
1	baloxavirIBA 12/2021
1	EndonucleasesIBA 12/2021
1	peramivirIBA 12/2021
1	laninamivirIBA 12/2021

Therapy/Procedure

13	Therapeutics 12/2021 - 11/2010
5	Art Therapy 01/2021 - 08/2010
4	Highly Active Antiretroviral Therapy (HAART) 10/2019 - 01/2009
3	Stem Cell Transplantation 05/2022 - 06/2006
3	Liver Transplantation 10/2021 - 01/2019
3	Artificial Respiration (Mechanical Ventilation) 02/2021 - 01/2021
2	Length of Stay 05/2022 - 12/2019
2	Critical Care (Surgical Intensive Care) 02/2022 - 01/2021
2	Immunomodulation 01/2022 - 08/2004
2	Transplantation 10/2021 - 01/2020
1	Patient Readmission 01/2022